Clinical Phase I study with an Insulin-like Growth Factor-1 Receptor Inhibitor: Experiences in patients with squamous non-small cell lung carcinoma

By Ekman Simon   Fröödin Jan-Erik   Harmenberg Johan   Bergman Antonina   Hedlund ÅÅsa   Dahg Pia   Alvfors Carina   Stååhl Birgitta   Bergströöm Stefan   Bergqvist Michael  

Acta Oncologica, Vol. 50, Iss. 3, 2011-04 ,pp. : 441-447

Informa Healthcare

Access to resources Recommend Favorite

From targets to targeted therapies and molecular profiling in non-small cell lung carcinoma

By Thomas A.   Rajan A.   Lopez-Chavez A.   Wang Y.   Giaccone G.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 577-585

Oxford University Press

Access to resources Recommend Favorite

Evaluation of carboplatin dosing in non-small cell lung carcinoma patients using Calvert formula and Cockroft and Gault equation for glomerular filtration rate estimation

By          

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 1072-1076

Spandidos Publications

Access to resources Recommend Favorite

Distinguishing Early-Stage Pancreatic Cancer Patients From Disease-Free Individuals Using Serum Profiling

By Hocker James R.   Lerner Megan R.   Mitchell Stephanie L.   Lightfoot Stan A.   Lander Theresa J.   Quillet Aurelien A.   Hanas Rushie J.   Peyton Marvin D.   Postier Russell G.   Brackett Daniel J.   Hanas Jay S.  

Cancer Investigation, Vol. 29, Iss. 2, 2011-01 ,pp. : 173-179

Informa Healthcare

Access to resources Recommend Favorite

Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients

By Zhong L.   Peng X.   Hidalgo G.E.   Doherty D.E.   Stromberg A.J.   Hirschowitz E.A.  

Cancer Detection and Prevention, Vol. 27, Iss. 4, 2003-01 ,pp. : 285-290

Elsevier

Access to resources Recommend Favorite